Health
Gout drug could reduce Covid hospital stays, new research finds – The Guardian
Colchicine also found to reduce need for extra oxygen and has potential to be used in outpatient settings
A cheap drug normally used to treat gout has been found to have the potential to significantly reduce hospital stays among Covid-19 patients and the need for extra oxygen.
The results of new research into colchicine conducted in Brazil come after an international trial published on Wednesday found that it reduced hospitalisations and deaths among Covid-19 patients by more than 20%.
Colchicine, which is used to treat rheumatic diseases, was hailed by researchers as having the potential to be the…
-
General16 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Business18 hours agoOrd Minnett names 2 ASX 200 shares to buy
-
Noosa News19 hours agoResident rushed to hospital with multiple burns as house engulfed in flames in Woodridge
-
Noosa News17 hours agoWhy the Brisbane City Hall clock has fallen silent